Published in MMWR Recomm Rep on April 04, 1997
Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol (2006) 5.95
Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol (2004) 3.96
2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol (2010) 3.32
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun (2001) 2.68
SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol (2008) 2.35
Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect Immun (2005) 2.32
Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med (2004) 2.23
Evaluation of semiautomated multiplex PCR assay for determination of Streptococcus pneumoniae serotypes and serogroups. J Clin Microbiol (2003) 2.14
Particle size distribution of airborne microorganisms and pathogens during an Intense African dust event in the eastern Mediterranean. Environ Health Perspect (2008) 1.86
Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis. J Clin Microbiol (2000) 1.80
Pneumococcal conjugate vaccine for adults: a new paradigm. Clin Infect Dis (2012) 1.78
Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children. J Med Microbiol (2008) 1.71
Preventive care in chronic liver disease. J Gen Intern Med (1999) 1.69
Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation. J Clin Microbiol (2003) 1.64
Role of diabetes in the development of acute respiratory distress syndrome. Crit Care Med (2013) 1.62
Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin Infect Dis (2008) 1.62
Vaccination in the elderly: an immunological perspective. Trends Immunol (2009) 1.60
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum (2012) 1.59
SHEA/APIC Guideline: Infection prevention and control in the long-term care facility. Am J Infect Control (2008) 1.56
Maternal vaccination: moving the science forward. Hum Reprod Update (2014) 1.50
Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract (2009) 1.40
Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin Diagn Lab Immunol (2003) 1.38
Using a summary measure for multiple quality indicators in primary care: the Summary QUality InDex (SQUID). Implement Sci (2007) 1.38
Interventions to increase influenza vaccination rates in veterans with spinal cord injuries and disorders. J Spinal Cord Med (2007) 1.36
The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur J Epidemiol (2004) 1.32
Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol (2008) 1.32
Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev (2012) 1.31
Racial/ethnic differences in adult vaccination among individuals with diabetes. Am J Public Health (2003) 1.30
In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother (2004) 1.30
Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study. J Clin Microbiol (2001) 1.29
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Fam Pract (2000) 1.26
Health disparities: a barrier to high-quality care. Am J Health Syst Pharm (2005) 1.24
A novel multiresistant Streptococcus pneumoniae serogroup 19 clone from Washington State identified by pulsed-field gel electrophoresis and restriction fragment length patterns. J Clin Microbiol (2000) 1.24
Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. BMJ (2012) 1.23
Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis. Ann Fam Med (2012) 1.21
Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J Clin Microbiol (2005) 1.16
Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. J Allergy Clin Immunol (2010) 1.16
Immunoreactivity of five monoclonal antibodies against the 37-kilodalton common cell wall protein (PsaA) of Streptococcus pneumoniae. Clin Diagn Lab Immunol (1998) 1.16
Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae. Infect Immun (2003) 1.15
Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev (2003) 1.15
Progress in the prevention of pneumococcal infection. CMAJ (2005) 1.14
Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia. J Infect Dis (2008) 1.14
Antibody responses to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques. Infect Immun (1998) 1.14
Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc (2006) 1.13
Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model. Infect Immun (2003) 1.09
CcpA-dependent and -independent control of beta-galactosidase expression in Streptococcus pneumoniae occurs via regulation of an upstream phosphotransferase system-encoding operon. J Bacteriol (2007) 1.08
Diversity of mutations in the atpC gene coding for the c Subunit of F0F1 ATPase in clinical isolates of optochin-resistant Streptococcus pneumoniae from Brazil. J Clin Microbiol (2007) 1.08
Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev (2000) 1.07
Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis (2007) 1.07
Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis (2006) 1.07
Clonal association between Streptococcus pneumoniae serotype 23A, circulating within the United States, and an internationally dispersed clone of serotype 23F. J Clin Microbiol (2005) 1.06
The burden of acute otitis media on the patient and the family. Eur J Pediatr (2003) 1.06
Pilot study of the genetic diversity of the pneumococcal nasopharyngeal flora among children attending day care centers. J Clin Microbiol (2002) 1.06
Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency. Vaccine (2008) 1.06
Racial disparities in receipt of influenza and pneumococcus vaccinations among US nursing-home residents. Am J Public Health (2010) 1.05
Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis (2009) 1.05
Improving pneumococcal vaccine rates. Nurse protocols versus clinical reminders. J Gen Intern Med (1999) 1.05
Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older. BMC Infect Dis (2010) 1.05
Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults. Epidemiol Infect (2008) 1.04
Clonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study. J Clin Microbiol (2000) 1.04
Multilocus sequence typing directly on DNA from clinical samples and a cultured isolate to investigate linked fatal pneumococcal disease in residents of a shelter for homeless men. J Clin Microbiol (2005) 1.04
Immunization needs of chronic liver disease patients seen in primary care versus specialist settings. Dig Dis Sci (2005) 1.03
Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Arthritis Res Ther (2010) 1.02
Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention. Can J Infect Dis Med Microbiol (2009) 1.01
Development and evaluation of a novel multiplex PCR technology for molecular differential detection of bacterial respiratory disease pathogens. J Clin Microbiol (2008) 1.01
Molecular analysis by pulsed-field gel electrophoresis and antibiogram of Streptococcus pneumoniae serotype 6B isolates from selected areas within the United States. J Clin Microbiol (1998) 1.01
Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis (2014) 1.01
Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment. Arthritis Res Ther (2010) 1.01
Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity. Infect Immun (2002) 1.00
Genetic characterization of optochin-susceptible viridans group streptococci. Antimicrob Agents Chemother (2003) 0.99
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 0.99
Molecular characterization of disease-associated streptococci of the mitis group that are optochin susceptible. J Clin Microbiol (2006) 0.99
Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera. Clin Vaccine Immunol (2010) 0.99
Invasive pneumococcal infections among persons with and without underlying medical conditions: implications for prevention strategies. BMC Infect Dis (2008) 0.98
Preventing infections in nursing homes: a survey of infection control practices in southeast Michigan. Am J Infect Control (2005) 0.98
Modeling of cost effectiveness of pneumococcal conjugate vaccination strategies in U.S. older adults. Am J Prev Med (2013) 0.98
Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies. Clin Diagn Lab Immunol (2003) 0.97
Vaccines for women age 50 and older. Emerg Infect Dis (2004) 0.97
New CDC recommendations: annual influenza vaccination recommended for individuals with spinal cord injuries. J Spinal Cord Med (2005) 0.97
Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up. BMC Public Health (2006) 0.97
Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice. Infect Immun (2007) 0.96
Response to Pneumococcal Polysaccharide Vaccination in HIV-Positive Individuals on Long Term Highly Active Antiretroviral Therapy. J AIDS Clin Res (2015) 0.96
Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years. Appl Health Econ Health Policy (2013) 0.95
Adult vaccination coverage levels among users of complementary/alternative medicine - results from the 2002 National Health Interview Survey (NHIS). BMC Complement Altern Med (2008) 0.95
B cell mediated priming following pneumococcal colonization. Vaccine (2006) 0.95
Low prevalence of pneumococcal carriage and high serotype and genotype diversity among adults over 60 years of age living in Portugal. PLoS One (2014) 0.95
Comprehensive Geriatric Assessment (CGA) in general practice: results from a pilot study in Vorarlberg, Austria. BMC Geriatr (2004) 0.94
Performance measures, vaccinations, and pneumonia rates among high-risk patients in Veterans Administration health care. Am J Public Health (2007) 0.94
Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae. Clin Vaccine Immunol (2006) 0.94
Molecular epidemiology of pneumococcal carriage among children with upper respiratory tract infections in Hanoi, Vietnam. J Clin Microbiol (2002) 0.94
Pneumococcal IgA1 protease subverts specific protection by human IgA1. Mucosal Immunol (2013) 0.94
Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. Aging Dis (2011) 0.93
The incidence rate and economic burden of community-acquired pneumonia in a working-age population. Am Health Drug Benefits (2013) 0.93
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy. Ann Rheum Dis (2013) 0.93
A comparison of multiple data sources to identify vaccinations for veterans with spinal cord injuries and disorders. J Am Med Inform Assoc (2004) 0.93
Effects of absorption with pneumococcal type 22F polysaccharide on maternal, cord blood, and infant immunoglobulin G antipneumococcal polysaccharide antibodies. Clin Diagn Lab Immunol (2005) 0.93
Race/ethnicity and validity of self-reported pneumococcal vaccination. BMC Public Health (2008) 0.93
Molecular epidemiology of penicillin-nonsusceptible Streptococcus pneumoniae among children in Greece. J Clin Microbiol (2000) 0.92